Log In
BCIQ
Print this Print this
 

CelleRx

  Manage Alerts
Collapse Summary General Information
Company NovaBay Pharmaceuticals Inc.
DescriptionTopical solution
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Dermatology (unspecified)
Indication DetailsTreat skin following aesthetic dermatology and plastic surgery procedures
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.3M

$0.3M

$1.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/16/2012

$1.3M

$0.3M

$1.0M

Get a free BioCentury trial today